Revista Egresados de Medicina UF – N°1

Bibliografía recomendada

Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J 2011;161:145-51.
Noakes M, Clifton PM. Weight loss and plasma lipids.CurrOpinLipidol 2000;11:65-70.
Halbert JA, Silagy CA, Finucane P, Withers RT, Hamdorf PA. Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials. Eur J ClinNutr 1999;53:514-22.
Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ 2011;342:d636.
Consenso de prevención cardiovascular de la Sociedad Argentina de Cardiología. RevArgCardiol 2011; 80 (Suplemento 2): 1-127.
Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, et al. AIM-HIGH Investigators.Niacin in Patients with Low HDL CholesterolLevels Receiving Intensive Statin Therapy. N Engl J Med 2011;365(24):2255-67.
Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, et al. HPS2-THRIVE Collaborative Group.Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014;371(3):203-12.
Ridker P, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, et al. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet 2010;376:333-9.